As of Oct 23
| +0.03 / +1.38%|
The 5 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 4.30, with a high estimate of 6.00 and a low estimate of 3.75. The median estimate represents a +94.57% increase from the last price of 2.21.
The current consensus among 5 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.